FOXO:NYE-FOXO Technologies Inc. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 0.2666

Change

-0.01 (-2.52)%

Market Cap

USD 2.94M

Volume

0.17M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+0.48 (+0.71%)

USD 10.78B
DOCS Doximity Inc

+0.46 (+1.06%)

USD 7.70B
WEAV Weave Communications Inc

+0.47 (+3.75%)

USD 0.89B
AMWL American Well Corp

+0.29 (+3.20%)

USD 0.14B
MPLN MultiPlan Corporation

+1.02 (+12.78%)

USD 0.12B
OWLT Owlet Inc

-0.07 (-1.53%)

USD 0.07B
STRM Streamline Health Solutions In..

+2.37 (+1,185.64%)

USD 0.01B
LFMDP LifeMD Inc Preferred Series A

-0.25 (-1.12%)

N/A
PHR Phreesia Inc

+0.12 (+0.54%)

N/A
VEEV Veeva Systems Inc Class A

+0.14 (+0.07%)

N/A

ETFs Containing FOXO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -16.61% 64% D 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -16.61% 64% D 11% F
Trailing 12 Months  
Capital Gain -87.00% 9% A- 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -87.00% 9% A- 1% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -40.77% 9% A- 1% F
Dividend Return -40.77% 9% A- 1% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 45.77% 64% D 20% F
Risk Adjusted Return -89.08% 27% F 2% F
Market Capitalization 2.94M 9% A- 2% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector